These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22933346)

  • 1. Bad kidneys are bad for the heart: but what can we do about it?
    Henry TD; Herzog CA
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):358-60. PubMed ID: 22933346
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
    Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
    Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chronic kidney disease on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or drug-eluting stents.
    Pan Y; Qiu Q; Chen F; Li X; Yu X; Luo Y; Li Q; He J; Gao Y; Zhang X; Ren X
    Coron Artery Dis; 2016 Nov; 27(7):535-42. PubMed ID: 27269882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Treatment Strategies in Patients with Chronic Kidney Disease and Coronary Artery Disease.
    Volodarskiy A; Kumar S; Amin S; Bangalore S
    Am J Med; 2016 Dec; 129(12):1288-1298. PubMed ID: 27476086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of renal function on platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention with stenting.
    Breet NJ; de Jong C; Bos WJ; van Werkum JW; Bouman HJ; Kelder JC; Bergmeijer TO; Zijlstra F; Hackeng CM; Ten Berg JM
    Thromb Haemost; 2014 Dec; 112(6):1174-81. PubMed ID: 25231776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials.
    Baber U; Giustino G; Sartori S; Aquino M; Stefanini GG; Steg PG; Windecker S; Leon MB; Wijns W; Serruys PW; Valgimigli M; Stone GW; Dangas GD; Morice MC; Camenzind E; Weisz G; Smits PC; Kandzari D; Von Birgelen C; Mastoris I; Galatius S; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Mehran R
    JACC Cardiovasc Interv; 2016 Jan; 9(1):28-38. PubMed ID: 26762908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One year clinical outcomes in patients with chronic kidney disease treated by percutaneous coronary intervention with drug-eluting stent.
    Barthelemy O; Helft G; Le Feuvre C
    Int J Cardiol; 2011 Mar; 147(2):307. PubMed ID: 21215476
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease.
    Siddiqi OK; Smoot KJ; Dufour AB; Cho K; Young M; Gagnon DR; Ly S; Temiyasathit S; Faxon DP; Gaziano JM; Kinlay S
    Heart; 2015 Oct; 101(19):1569-76. PubMed ID: 26209334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention.
    Gupta T; Paul N; Kolte D; Harikrishnan P; Khera S; Aronow WS; Mujib M; Palaniswamy C; Sule S; Jain D; Ahmed A; Cooper HA; Frishman WH; Bhatt DL; Fonarow GC; Panza JA
    J Am Heart Assoc; 2015 Jun; 4(6):e002069. PubMed ID: 26080814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Chronic Kidney Disease on Long-Term Outcomes in Type 2 Diabetic Patients With Coronary Artery Disease on Surgical, Angioplasty, or Medical Treatment.
    Lima EG; Hueb W; Gersh BJ; Rezende PC; Garzillo CL; Favarato D; Hueb AC; Rahmi Garcia RM; Franchini Ramires JA; Filho RK
    Ann Thorac Surg; 2016 May; 101(5):1735-44. PubMed ID: 26794894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term patient and kidney survival after coronary artery bypass grafting, percutaneous coronary intervention, or medical therapy for patients with chronic kidney disease: a propensity-matched cohort study.
    Vuurmans T; Er L; Sirker A; Djurdjev O; Simkus G; Levin A
    Coron Artery Dis; 2018 Jan; 29(1):8-16. PubMed ID: 28938241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of chronic kidney disease among patients undergoing transradial percutaneous coronary interventions.
    Hossain MA; Quinlan A; Heck-Kanellidis J; Calderon D; Patel T; Gandhi B; Patel S; Hetavi M; Costanzo EJ; Cosentino J; Patel C; Dewan A; Kuo YH; Salman L; Vachharajani TJ
    J Vasc Access; 2018 Jul; 19(4):346-349. PubMed ID: 29529964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
    Grandjean-Thomsen NL; Marley P; Shadbolt B; Farshid A
    Nephron; 2017; 137(1):23-28. PubMed ID: 28478459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease and the risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents.
    Miao Y; Yu-Jie Z; Zhi-Jian W; Dong-Mei S; Yu-Yang L; Ying-Xin Z; Fei G; Shi-Wei Y; De-An J
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):361-7. PubMed ID: 22419375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revascularization options in patients with chronic kidney disease.
    Ashrith G; Elayda MA; Wilson JM
    Tex Heart Inst J; 2010; 37(1):9-18. PubMed ID: 20200622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in patients with renal impairment undergoing percutaneous coronary intervention and implantation of the Endeavor zotarolimus-eluting stent: 1- and 2-year data from the E-Five Registry.
    Rothman MT; Jain AK;
    Catheter Cardiovasc Interv; 2012 Nov; 80(6):885-92. PubMed ID: 22517785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of chronic kidney disease on long-term clinical outcomes after percutaneous coronary intervention with drug-eluting or bare-metal stents.
    Kersting S; Grumann T; Hummel J; Hauschke D; Bode C; Hehrlein C
    Crit Pathw Cardiol; 2012 Sep; 11(3):152-9. PubMed ID: 22825536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention.
    Kitai Y; Ozasa N; Morimoto T; Bao B; Furukawa Y; Nakagawa Y; Kadota K; Yanagita M; Shizuta S; Kimura T;
    Int J Cardiol; 2013 Oct; 168(6):5221-8. PubMed ID: 23998544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.